ELISA Technologies Market Size, Share, Growth, and Industry Analysis, By Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA), By Application (Academia, Blood Banks, Hospitals, Pharma & Biotechnology Companies, Laboratories, Others), Regional Insights and Forecast To 2032

• 

  Request a Free sample to learn more about this report

ELISA TECHNOLOGIES MARKET OVERVIEW

Global ELISA technologies market size was anticipated to be worth USD 0.19 million in 2023 and is expected to reach USD 0.25 million by 2032 at a CAGR of 3.6% during the forecast period.

An immunological method frequently used to quantify antibodies, antigens, proteins, and glycoproteins in biological materials is the enzyme-linked immunosorbent assay (ELISA). Pregnancy tests, the identification of HIV infection, and the measuring of cytokines or soluble receptors in serum or cell supernatant are a few examples. ELISA tests may assess several samples in a single experiment since they are often run on 96-well plates. To guarantee that the antibody or antigen adheres to the surface, these plates must be unique absorbent plates (such as NUNC Immuno plates). Since kits for a large range of antigens are readily accessible, each ELISA measures a particular antigen.

Several elements, such as increase in chronic illnesses, the demand for diagnostic tests are fuelling the enzyme-linked immunosorbe­nt assay (ELISA) market's growth. Technological breakthroughs allow doctors and researchers to detect and count a broader mix of analytics using more accurate and particular ELISA kits. ELISA procedures are automated, leading to better productivity and faster results, a boon for high throughput screening needs. The spike in diagnostic testing needs, particularly in budding nations, boosts the ELISA technology market.

COVID-19 IMPACT

Market Growth Hampered by Pandemic Due to Disruptions In Supply Chains

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has had a severe effect on the ELISA technology industry. The pandemic shifted resources significantly towards COVID-19 testing and vaccine development, disrupted supply networks, and decreased demand for medical diagnostics unrelated to COVID. Consequently, several ELISA technology enterprises encountered obstacles including reduced revenue, postponed product introductions, and issues obtaining raw materials. Furthermore, the pandemic has resulted in a decrease in standard medical examinations and screenings, which is a major driver of ELISA test demand. Routine operations and non-urgent medical tests have been delayed or postponed because to the COVID-19 pandemic overloading healthcare systems, which has further affected the ELISA market.

LATEST TRENDS

Rising Use of Robots and Automation to Drive Market Growth

One of the most significant advancements is the creation of multiplex ELISA assays, which allow for the simultaneous detection of several analytes in a single sample. This improves productivity, lowers expenses, and permits thorough profiling of environmental variables or complicated illnesses. Another trend is the use of robots and automation with ELISA to streamline processes and cut down on manual labour. This is particularly helpful for large-scale testing in clinical and industrial labs. Furthermore, because point-of-care (POC) ELISA tests offer a rapid and simple diagnosis at the bedside or in rural areas, their significance is growing. These diagnostics, which provide quick data for efficient disease management, are particularly important in locations with limited resources or during epidemics. Furthermore, assay is being revolutionised by the introduction of new ELISA technologies, such as digital ELISA and microfluidic-based platforms.

Request a Free sample to learn more about this report

ELISA TECHNOLOGIES MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA.

• Sandwich ELISA: This kind of ELISA uses two separate antibodies to bind to distinct locations on the target protein known as epitopes. The main immunizer is formed to a catalyst and immobilized on a strong help, such a microplate, while the subsequent neutralizer is acquainted with the sample.

• Indirect ELISA: One antibody is utilised in the detection of the target protein in an indirect ELISA. The sample is placed onto the plate once the antibody has been rendered immobile on a solid surface. If there is an immobilised antibody in the sample, the target protein will bind to it. After that, a second enzyme-linked antibody that is added to form a "sandwich" structure recognises the first antibody.

• Multiple and portable ELISA: These ELISA technologies are used in situations where conventional laboratory equipment is neither viable nor readily available. Portable ELISA systems lightweight and portable, which makes them perfect for usage in resource-constrained situations or field settings.

By Application

Based on application the global market can be categorized into Academia, Blood Banks, Hospitals, Pharma & Biotechnology Companies, Laboratories, Others.

• Academia: Academic research uses ELISA technology to examine a range of biological processes, illnesses, and medication development.

• Blood Banks: Blood banks use ELISA technology to test blood samples for infectious disorders including syphilis, HIV, and hepatitis B and C.

• Hospitals: ELISA technologies are used in hospitals to identify infectious infections, autoimmune disorders, and cancer cancer cancer biologics/biomarkers, among other diagnostic uses.

• Pharma & Biotechnology Companies: ELISA technologies are used by pharmaceutical and biotech firms for quality control, medication development, and discovery.

• Laboratories: ELISA technology is used in research labs for Basic research, medication development, and clinical diagnostics.

• Others: ELISA technologies also find application in veterinary medicine, food safety, environmental monitoring, forensic research, and other industries.

DRIVING FACTORS

Increasing Awareness about Infectious Diseases to Boost the Market Growth

Worldwide, the variety of uses for immunoassay-based diagnostics is growing significantly. Campaigns to raise public awareness are started in order to recognise the signs of infectious illnesses like HIV and figure out how to avoid them. Consequently, there is an increasing need for immunoassays due to increased patient awareness. For example, the International Society for Infectious Diseases' advocacy programme worked with doctors, researchers, and public health practitioners all across the world. It backed the dissemination of scientific information as well as the use of evidence-based medicine and public health initiatives. As a result, this component encourages market expansion. Sandwich ELISA is frequently used to identify immune responses, which is fuelling the ELISA technologies market growth. Since several antibodies attach to the same antigen for identification or detection, this form of test is also the most sensitive, flexible, and specific. Sandwich ELISA has the primary benefit of not requiring sample purification prior to analysis. This helps a lot of firms save time. This element so promotes market expansion.

Rising Incidence of Chronic Diseases to Expand the Market

Because of the rising population and the increasing occurrence of ongoing illness including cancer, diabetes, and cardiovascular infections, there is a rising requirement for diagnostic tests, including ELISA. Thus, the creation and promotion of ELISA units for specific illness has risen. The improvement of more exact and delicate ELISA packs because of mechanical enhancements has supported their utilization in different applications. ELISA tests are being involved increasingly more by scientists and clinical experts for disease determination, drug advancement, and following patient responses to treatment. To create novel things and expand their item contributions, significant organizations in the market are likewise putting more in innovative work. Latest ELISA technologies are also being developed due to alliances and cooperation between universities, research centres, and business entities.

RESTRAINING FACTORS

High Costs of ELISA testing to Impede Market Growth

The primary obstacle to market expansion is the rising cost of ELISA testing. It takes sophisticated methods and pricey culture media to process this exam. Additionally, a single error might force the test to be restarted, which is why it demands a large quantity of culture materials. As a result, this issue limits market expansion.

• Request a Free sample to learn more about this report

•  

ELISA TECHNOLOGIES MARKET REGIONAL INSIGHTS

North America to Dominate in the Market due to Presence of a Large Consumer Base

The market is segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America has emerged as the most dominant region in the global ELISA technologies market share because of the region's quick advancements in healthcare facilities and infrastructure. Furthermore, the market in North America is expanding due to the region's adoption of advanced medical technologies and services. Furthermore, because ELISA tests are expensive and need great sensitivity and precision, it is expected that the nation's economy and individual consumers' purchasing power would increase demand for these tests.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The ELISA technologies market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features in ELISA technologies, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

List of Top Elisa Technologies Companies

• American Laboratory Products Company (ALPCO) (U.S.)
• BD Biosciences (U.S.)
• BioMérieux SA (France)
• Bio-Rad Laboratories (U.S.)
• EMD Millipore Corp (U.S.)
• Life Technologies Corporation (U.S.)
• Ortho-Clinical Diagnostics (U.S.)

INDUSTRIAL DEVELOPMENT

September 2022: J Mitra has lanuched fourth generation Elisa-based HCV test that is known as the HCV Gen 4 Ag and Ab Microlisa.  4th Generation HCV Microlisa is nothing but an in-vitro qualitative enzyme-linked immunosorbent assay that is used for find HCV core antigen and antibodies against HCV in human serum or plasma.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.